Arnold & Porter Advises Aurobindo Pharma in FTC Clearance for Acquisition of Lannett Company
Arnold & Porter recently represented Aurobindo Pharma Limited in obtaining Federal Trade Commission (FTC) clearance for its acquisition of Lannett Company, Inc., a manufacturer of generic…
Read the full articleYou might also wanna read
FTC Takes Action to Protect Americans from Higher Drug Costs in Aurobindo, Lannett Deal
Proposed FTC order requires divestiture of four drug products to resolve anticompetitive concerns The Federal Trade Commission took action t
FTC Files Amicus Brief to Protect Consumers from Pharmaceutical Monopolies
The Federal Trade Commission filed an amicus brief in an antitrust case alleging that drug manufacturer Johnson & Johnson illegally maintain
FTC Proposes Order to Resolve Anticompetitive Practices and Protect Healthcare Consumers
Author: Amy Asubonteng June 26, 2026 HRRC supports both the press release and the call to action given by the Federal Trade Commission. As h
Paramount-Warner Bros. Discovery $110B Merger Set for EU Antitrust Clearance With Conditions, FT Reports
Paramount's $110 billion merger with Warner Bros. Discovery is inching closer to approval in Europe, according to a report in the Financial
Deadline·16d agoAnnouncement: Bergeson & Campbell, P.C. to Cover NAW v. Feldon Bench Trial
The Bergeson & Campbell, P.C. (B&C®) Product Stewardship team is excited to announce daily coverage of the bench trial for National Associat
FDA Drug Regulator Accused of Targeting Former Business Associate's Pharmaceutical Company
FDA regulator accused of using position to exact revenge on old business associate.
arstechnica.com·8mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.